Weight gain and diabetes with “second‐generation” antipsychotic drugs

Firestone, Andrew

doi:10.5694/j.1326-5377.2005.tb06860.x

Cited by 3 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For most people with schizophrenia, taking medication is imperative to maintain emotional stability. However, adverse effects from psychiatric medications are relatively common and diverse in nature (Firestone 2005, Muir‐Cochrane & Wand 2005). The range of medications affecting body systems has been well documented.…”

Section: Medical Co‐morbidity In Schizophreniamentioning

confidence: 99%

Medical co‐morbidity risk factors and barriers to care for people with schizophrenia

Muir‐Cochrane

2006

Psychiatric Ment Health Nurs

View full text Add to dashboard Cite

The management of risk is a fundamental component of the work of mental health nurses and is most commonly associated with aggressive, violent and suicidal behaviours exhibited by those suffering from mental illness. However, people with severe mental illness are increasingly at risk of experiencing a number of related and complex health problems that include obesity, diabetes and cardiovascular disease. This group also has much higher rates of morbidity and mortality than that of the general population resulting in high social, economic and individual costs. Some of the barriers to receiving prompt and appropriate physical health care include lack of recognition by health professionals and the difficulties faced by consumers of mental health services in negotiating the health care system. Establishment of comprehensive (addressing both physical and mental health issues) programmes of care can address this need and offer additional opportunities for closer and more collaborative nurse-patient relationships. This paper explores risk factors for medical co-morbidity for people living with schizophrenia and suggests strategies that can facilitate better health outcomes.

show abstract

Section: Medical Co‐morbidity In Schizophreniamentioning

confidence: 99%

Medical co‐morbidity risk factors and barriers to care for people with schizophrenia

Muir‐Cochrane

2006

Psychiatric Ment Health Nurs

View full text Add to dashboard Cite

show abstract

Current awareness: Pharmacoepidemiology and drug safety

2006

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 20 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract